Horsham, United Kingdom

Gurdip Bhalay

USPTO Granted Patents = 16 


 

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • West Sussex, GB (2010)
  • Horsham, GB (2000 - 2017)

Company Filing History:


Years Active: 2000-2017

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: **Innovative Contributions of Gurdip Bhalay in Epithelial Sodium Channel Blockade**

Introduction

Gurdip Bhalay, an accomplished inventor based in Horsham, GB, has made significant strides in the realm of pharmaceuticals, particularly in the treatment of diseases influenced by the epithelial sodium channel (ENaC). With a robust portfolio comprising 16 patents, Bhalay has focused on innovative compounds that offer therapeutic solutions in critical health challenges.

Latest Patents

Among his latest patents, Gurdip Bhalay has developed remarkable compounds such as "Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives." These compounds, detailed as having a Formula I in free, salt, or solvate form, demonstrate utility in treating conditions responsive to ENaC blockade. The patent also outlines associated pharmaceutical compositions and methodologies for synthesizing these beneficial compounds. Additionally, the innovation includes "Pyrazine derivatives as ENaC blockers," which expands on the applications of these effective therapeutic agents, particularly emphasizing their pharmaceutical viability and the processes associated with their development.

Career Highlights

Bhalay's association with Novartis AG has been a defining aspect of his career. Within this prestigious pharmaceutical company, he has played a pivotal role in pioneering research aimed at addressing significant health issues through innovative approaches. His work not only highlights his inventive capabilities but also emphasizes his commitment to advancing medical science and improving patient outcomes.

Collaborations

In his journey of innovation, Gurdip has collaborated with esteemed colleagues such as Stephen Paul Collingwood and Lee Edwards. These collaborations foster an environment of shared knowledge and expertise, resulting in enhanced research outcomes and significant contributions to the field of pharmacology.

Conclusion

Gurdip Bhalay continues to shape the landscape of medical treatment through his dedicated work and inventive spirit. With a comprehensive portfolio of patents and collaborations with respected professionals, Bhalay’s contributions are vital to the ongoing effort to develop effective therapies for diseases mediated by epithelial sodium channels. His work exemplifies the impact that dedicated inventors can have on improving health and wellness in society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…